Axillary sentinel lymph node micrometastases with extracapsular extension: A distinct pattern of breast cancer metastasis?

Journal of Clinical Pathology

Volumn 61, Issue 1, 2008, Pages 115-118

  Cserni, Gábor ^a  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CARCINOMA; CORRELATION COEFFICIENT; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; MICROMETASTASIS; PARENCHYMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; ADENOCARCINOMA; AXILLA; BIOPSY; BREAST TUMOR; CANCER INVASION; FEMALE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PAGET NIPPLE DISEASE; PATHOLOGY;

ADENOCARCINOMA; AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; SENTINEL LYMPH NODE BIOPSY;

EID: 38449085804     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.047357     Document Type: Article

References (41)

1. Pierce LJ, Oberman HA, Strawderman MH, et al. Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 1995;33:253-9.
2. Hetelekidis S, Schnitt SJ, Silver B, et al. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int J Radiat Oncol Biol Phys 2000;46:31-4.
3. Fisher BJ, Perera FE, Cooke AL, et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Int J Radiat Oncol Biol Phys 1997;38:551-9.
4. Neri A, Marrelli D, Roviello F, et al. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer. Ann Surg Oncol 2005;12:246-53.
5. Stranzl H, Ofner P, Peintinger F. postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes : is there an impact of axillary extranodal tumor extension on locoregional and distant control? Strahlenther Onkol 2006;182:583-8.
6. Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 1993;72:778-82.
7. Stranzl H, Mayer R, Ofner P, et al. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation. Strahlenther Onkol 2004;180:31-7.
8. Goyal A, Douglas-Jones AG, Newcombe RG, et al. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer. Breast J 2005;11:188-94.
9. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-81.
10. Cserni G. Sentinel lymph node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol 2001;27:532-8.
11. Degnim AC, Griffith KA, Sabel MS, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 2003;98:2307-15.
12. Stitzenberg KB, Meyer AA, Stern SL, et al. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg 2003;237:607-13.
13. Changsri C, Prakash S, Sandweiss L, et al. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J 2004;10:392-7.
14. Joseph KA, El-Tamer M, Komenaka I, et al. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 2004;139:648-51.
15. Saidi RF, Dudrick PS, Remine SG, et al. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 2004;70:101-5.
16. Cserni G, Burzykowski T, Vinh-Hung V, et al. Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 2004;34:519-24.
17. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1995;76:1491-512.
18. Rutgers EJ, Meijnen P, Bonnefoi H, et al. Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res 2004;6:165-9.
19. Cserni G, Rajtár M, Boross G, et al. Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer. World J Surg 2002;26:592-7.
20. Cserni G. Complete step sectioning of axillary sentinel lymph nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002;55:926-31.
21. Cserni G. Surgical pathological staging of breast cancer by sentinel lymph node biopsy with special emphasis on the histological work-up of axillary sentinel lymph nodes. Breast Cancer 2004;11:242-9.
22. Cserni G, Boross G, Baltás B. Value of axillary sentinel nodal status in breast cancer. World J Surg 2000;24:341-4.
23. Cserni G. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2001;67:86-91.
24. Cserni G. Effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2003;69:419-23.
25. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work-up. J Clin Pathol 1999;52:922-4.
26. Hermanek P, Hutter RVP, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-73.
27. Sobin LH, Wittekind C, eds. UICC TNM classification of malignant tumours. 6th edn. New York: John Wiley and Sons, 2002:10-13.
28. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook - TNM classification of malignant tumors. 6th edn. New York: Springer Verlag, 2002:257-81.
29. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2005;103:358-67.
30. Cserni G, Sapino A, Decker T. Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 2006;15:347-54.
31. Kirkham N, Cotton DW. Measuring melanomas: the Vernier method. J Clin Pathol 1984;37:229-30.
32. Palamba HW, Rombouts MC, Ruers TJ, et al. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes. Eur J Surg Oncol 2001;27:719-22.
33. Nga ME, Putti TC. Glandular structures in an intraoperative axillary sentinel lymph node biopsy: a diagnostic dilemma. Histopathology 2005;48:475-7.
34. Cserni G, Bianchi S, Vezzosi V, et al. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma. J Clin Pathol 2006;59:518-22.
35. Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol 1999;23:1561.
36. Tsuda H, Takarabe T, Hirohashi S. Correlation of numerical and structural status of chromosome 16 with histological type and grade of non-invasive and invasive breast carcinomas. Int J Cancer 1999;84:381-7.
37. Buerger H, Otterbach F, Simon R, et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999;189:521-6.
38. Green I, McCormick B, Cranor M, et al. A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol 1997;21:653-7.
39. Gunhan-Bilgen I, Oktay A. Tubular carcinoma of the breast: mammographic, sonographic, clinical and pathologic findings. Eur J Radiol 2007;61:158-62.
40. Eusebi V, Foschini MP, Betts CM, et al. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison. Am J Surg Pathol 1993;17:99-109.
41. Gusterson BA, Warburton MJ, Mitchell D, et al. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 1982;42:4763- 70.